Home / Tolterodine / Norway
NO ATC G04BD07 · updated 2 Nov 2026
Tolterodine shortage in Norway
Is there a Tolterodine shortage in Norway?
Yes. As of 2 Nov 2026, 2 Tolterodine products are reported short in Norway, the first since 30 Jan 2026. The company estimate for the return is 25 Jan 2027 (latest 10 Mar 2027). Main reason: increased demand.
Also short in Canada, Germany, Spain, Ireland, Austria, Belgium, Sweden. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Tolterodine Sandoz 2 mg depotkapsel, hard, 60 stk boks | Sandoz | 30 Jan 2026 | 10 Mar 2027 | Increased demand Uventet økt etterspørsel |
| NO | Tolterodine Sandoz 4 mg depotkapsel, hard, 84 stk blisterpakning | Sandoz | 30 Jan 2026 | 25 Jan 2027 | Manufacturing problem Produksjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).